Stocktoria
Lite Strategy, Inc. LITS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2003-12-18
Lite Strategy, Inc. statistics & valuation
Market cap$30.6M
P / B1.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | 22.3% | -75.3% | -185.5% | -173.7% |
| Net margin | — | 27.2% | -65.6% | -133.8% | -118.7% |
| FCF margin | — | -77.3% | -107.6% | -121.0% | -93.9% |
| Return on assets | -87.2% | 43.0% | -26.5% | -30.6% | -23.7% |
| Return on equity | -94.2% | 53.8% | -130.0% | -103.9% | -83.5% |
| Current ratio | 13.50 | 4.88 | 5.29 | 6.84 | 8.15 |
| Revenue growth | -100.0% | 33.8% | 19.9% | 17.0% | 25.4% |
Source: SEC EDGAR filings · CIK 0001262104 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.